Concepedia

The Economic Impact on Australian Patients with Neuroendocrine Tumours

Louisa G. Gordon, Thomas M. Elliott, Kate Wakelin, Simone Leyden, John Leyden, Michael Michael, Nick Pavlakis, Jan Mumford, Eva Segelov, David Wyld

Patient · 2020 · 18 citations · 18 references

DOI

Concepts

References

18

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari, Chan Shen, Daniel M. Halperin et al. · JAMA Oncology · 2017 · 3.5K citations · Full text

, , +17

Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

Jonas A. de Souza, Bonnie J. Yap, Kristen Wroblewski et al. · Cancer · 2016 · 882 citations · Full text

, , +16

Health-related quality of life measured using the EQ-5D–5L: South Australian population norms

Nikki McCaffrey, Billingsley Kaambwa, David C. Currow et al. · Health and Quality of Life Outcomes · 2016 · 501 citations · Full text

, , +16

A Pilot Discrete Choice Experiment to Explore Preferences for EQ-5D-5L Health States

Richard Norman, Paula Cronin, Rosalie Viney · Applied Health Economics and Health Policy · 2013 · 211 citations

, , +11

Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs

Simron Singh, Edward M. Wolin, Richard R.P. Warner et al. · Journal of Global Oncology · 2016 · 158 citations · Full text

, , +16